Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Oliver Buchhave Pedersen, Sanne Bøjet Larsen, Steen Dalby Kristensen, Anne-Mette Hvas & Erik Lerkevang Grove. (2023) Immature platelets and cardiovascular events in patients with stable coronary artery disease. Platelets 34:1.
Read now
Read now
Kristian H. Christensen, Erik L. Grove, Morten Würtz, Steen D. Kristensen & Anne-Mette Hvas. (2015) Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes. Platelets 26:3, pages 230-235.
Read now
Read now
Articles from other publishers (20)
Oliver Buchhave Pedersen, Anne-Mette Hvas, Leonardo Pasalic, Steen Dalby Kristensen, Erik Lerkevang Grove & Peter H. Nissen. (2023) Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction. Thrombosis and Haemostasis.
Crossref
Crossref
Oliver Buchhave Pedersen, Erik Lerkevang Grove, Steen Dalby Kristensen, Peter H. Nissen & Anne-Mette Hvas. (2021) MicroRNA as Biomarkers for Platelet Function and Maturity in Patients with Cardiovascular Disease. Thrombosis and Haemostasis 122:02, pages 181-195.
Crossref
Crossref
Maria de Fátima Brito, Carla Torre & Beatriz Silva-Lima. (2021) Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative. Frontiers in Medicine 8.
Crossref
Crossref
Beatrice Mainoli, Gonçalo S. Duarte, João Costa, Joaquim Ferreira & Daniel Caldeira. (2020) Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis. American Journal of Cardiovascular Drugs 21:1, pages 63-71.
Crossref
Crossref
Nameer van Oosterom, Michael Barras, Robert Bird, Iulian Nusem & Neil Cottrell. (2020) A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery. Drugs 80:18, pages 1889-1899.
Crossref
Crossref
Philipp Mourikis, Saif Zako, Lisa Dannenberg, Carolin Helten, David Naguib, Thomas Hohlfeld, Tobias Petzold, Bodo Levkau, Tobias Zeus, Malte Kelm & Amin Polzin. (2020) Aspirin antiplatelet effects are associated with body weight. Vascular Pharmacology 125-126, pages 106635.
Crossref
Crossref
Márcia Ferreira, Margarida Freitas-Silva, Joana Assis, Ricardo Pinto, José P Nunes & Rui Medeiros. (2020) The emergent phenomenon of aspirin resistance: insights from genetic association studies. Pharmacogenomics 21:2, pages 125-140.
Crossref
Crossref
Antonis Voutetakis, Panagiota Pervanidou & Christina Kanaka-Gantenbein. (2020) Vital Considerations for Aspirin in Prevention of Preeclampsia, a Multifaceted Pregnancy Disorder—Reply. JAMA Pediatrics 174:1, pages 95.
Crossref
Crossref
Nicholas B. Norgard, Priya Jain & Jonathon R. Enriquez. 2019. Frontiers in Cardiovascular Drug Discovery: Volume 4. Frontiers in Cardiovascular Drug Discovery: Volume 4
1
15
.
Matthew M. Finneran, Veronica M. Gonzalez-Brown, Devin D. Smith, Mark B. Landon & Kara M. Rood. (2019) Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin. American Journal of Obstetrics and Gynecology 220:4, pages 385.e1-385.e6.
Crossref
Crossref
Mhamad Faour, Nicolas S. Piuzzi, David P. Brigati, Alison K. Klika, Michael A. Mont, Wael K. Barsoum & Carlos A. Higuera. (2018) Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty. The Journal of Arthroplasty 33:7, pages S131-S135.
Crossref
Crossref
Nicholas B. Norgard. (2017) Obesity and Altered Aspirin Pharmacology. Clinical Pharmacokinetics 57:6, pages 663-672.
Crossref
Crossref
Nicholas B. Norgard, Scott V. Monte, Stanley F. Fernandez & Qing Ma. (2017) Aspirin responsiveness changes in obese patients following bariatric surgery. Cardiovascular Therapeutics 35:4, pages e12268.
Crossref
Crossref
Andrea Schmitz, Larissa Romann, Peter Kienbaum, Goran Pavlaković, Robert Werdehausen & Thomas Hohlfeld. (2017) Dipyrone (metamizole) markedly interferes with platelet inhibition by aspirin in patients with acute and chronic pain. European Journal of Anaesthesiology 34:5, pages 288-296.
Crossref
Crossref
Nicholas W. Russo, Giovanna Petrucci & Bianca Rocca. (2016) Aspirin, stroke and drug-drug interactions. Vascular Pharmacology 87, pages 14-22.
Crossref
Crossref
D Bem, M Lordkipanidzé, J Hodgkinson, S Stevens, S Bayliss, D Moore, D Fitzmaurice & J Dretzke. (2016) The Effects of Different Aspirin Dosing Frequencies and the Timing of Aspirin Intake in Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review. Clinical Pharmacology & Therapeutics 100:5, pages 500-512.
Crossref
Crossref
Danai Bem, Janine Dretzke, Simon Stevens, Marie Lordkipanidzé, James Hodgkinson, Sue Bayliss, David Moore & David Fitzmaurice. (2015) Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review. Systematic Reviews 4:1.
Crossref
Crossref
Thomas HoeferPaul C. ArmstrongMichaela FinsterbuschMelissa V. ChanNicholas S. KirkbyTimothy D. Warner. (2015) Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy. Arteriosclerosis, Thrombosis, and Vascular Biology 35:10, pages 2122-2133.
Crossref
Crossref
Sanne Bøjet Larsen, Erik Lerkevang Grove, Søs Neergaard-Petersen, Morten Würtz, Anne-Mette Hvas & Steen Dalby Kristensen. (2015) Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease. PLOS ONE 10:5, pages e0126767.
Crossref
Crossref
L. A. Livshits, S. A. Kravchenko, M. V. Nechyporenko, V. M. Pampukha, N. V. Hryshchenko, G. B. Livshyts, O. O. Soloviov, P. F. Tatarskyy, O. A. Fesai, S. Yu. Chernushyn, A. M. Kucherenko & R. V. Gulkovskyy. (2013) Human genome mutation and rearrangement studies – the way to investigate monogenic and complex disease pathogenesis. Biopolymers and Cell 29:4, pages 330-338.
Crossref
Crossref